Summit Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Hi everyone, and welcome to the 41st Annual J.P. Morgan Healthcare Conference. My name is Natalie Collins, and I'm an associate in the J.P. Morgan healthcare investment banking team.
Just a reminder, we'll follow a 20-minute presentation format, followed by 20 minutes of Q&A. And with that, I'm thrilled to introduce the CEO, Bob Duggan; and co-CEO, Maky Zanganeh, of Summit Therapeutics.
Thank you, Natalie.
(video playing)
Thank you, Shelley. Good afternoon. My name is Maky Zanganeh, the co-CEO at -- and President of Summit Therapeutics. I would like to thank J.P. Morgan team today, especially Mike Gaito, for inviting us to present our company, Summit Therapeutics.
These are forward-looking statements. We take no responsibility in updating any forward-looking statements that we will make in this presentation. I would like to start to give you an update about our Summit company.
Summit became a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
